The Birmingham hospital is now using dissolvable stents for patients who need treatment for peripheral arterial disease.

Researchers at Baylor College of Medicine and collaborating institutions have discovered a mechanism that drives the ...

Researchers have discovered a mechanism that drives the long-term decline in immune response that is observed after tuberculosis (TB) has been successfully treated. Their findings suggest a potential ...

Belzutifan improved progression-free survival and objective response rate compared to everolimus in previously treated ...

Rapamycin is typically prescribed to organ transplant patients to suppress their immune systems. But many scientists and ...

Researchers at Baylor College of Medicine and collaborating institutions have discovered a mechanism that drives the long-term decline in immune response that is observed after tuberculosis (TB) has ...

Researchers at Baylor College of Medicine and collaborating institutions have discovered a mechanism that drives the ...

Researchers at Baylor College of Medicine and collaborating institutions have discovered a mechanism that drives the long-term decline in immune response that is observed after tuberculosis (TB) has ...

Anyone can invest, but building a successful investment portfolio takes a combination of a few things: research, patience, and a little bit of risk. So, if you had invested in Boston Scientific a ...

During a Case-Based Roundtable® event, Virginia F. Borges, MD, MMSc, discussed treatment selection for a patient with ER+, ...

Patients with previously treated advanced clear cell renal cell carcinoma (RCC) — a type of kidney cancer — experienced improvements in progression and response via treatment with Welireg (belzutifan) ...

Afinitor (everolimus) is a prescription drug that’s used to treat some types of cancer, seizures, and certain tumors. This drug can interact with other medications and some supplements.